Recall Register

Drug recall: Lansoprazole Delayed-Release Capsules, USP, 15 mg, a) 30-count bottle, (NDC 55111-398-30), b) 90-count bottle…

Class II FDA enforcement event 89871. Recall start date: . Status in the FDA record: Terminated. Termination date: .

Reason for recall, in the words of FDA

Failed Dissolution Specifications; during long term stability testing.

Class II, in the words of FDA

a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote

The recalling firm started this drug recall on 23 Mar 2022. The FDA record names a person as the firm, and this site does not show the name. The firm address in the FDA record is in Princeton, NJ. FDA put the recall in Class II. FDA event 89871 has 2 product records. The first FDA enforcement report date is 6 Apr 2022. The record gives the status Terminated, with the termination date 2 Feb 2024.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

Nationwide in the USA

Recalling firm

The name is withheld, Princeton, NJ.

The FDA record gives the name of a person as the recalling firm. This site does not show the names of persons.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

2 product records in the event.

FDA event 89871: product records
Recall numberProductQuantityClassStatusReport date
D-0737-2022Lansoprazole Delayed-Release Capsules, USP, 15 mg, a) 30-count bottle, (NDC 55111-398-30), b) 90-count bottle, (55111-398-90), Rx Only, Manufactured. By: Dr. Reddy's Laboratories Limited, Bachupally - 500 090, India8,352 bottles (30-count), 1,368 bottles (90-count)Class IITerminated6 Apr 2022
D-0738-2022Lansoprazole Delayed-Release Capsules, USP, 30 mg, 90-count bottle, Rx Only, Manufactured By: Dr. Reddy's Laboratories Limited, Bachupally - 500 090, India, NDC 55111-399-90.7,703 bottlesClass IITerminated6 Apr 2022

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class II: The middle of the three FDA recall classes.

The event in context

Drug events that started in 2022
325
Share of these events in Class II
65%
Product records in this event
2

Official channels

Cite this page

Recall Register. FDA enforcement event 89871. https://recallregister.com/fda/ii/89871/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA drug enforcement reports
Licence
CC0 1.0
Export date
28 Sep 2026
Newest FDA report date on the register
23 Sep 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: Nationwide in the USA
What quantity of product is in FDA event 89871?
The event has 2 product records. The first record gives this quantity: 8,352 bottles (30-count), 1,368 bottles (90-count)
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many drug recalls of 2022 have the same class?
65% of the 325 drug events that started in 2022 are in Class II.